US Bancorp’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,990
| Closed | -$8K | – | 4333 |
|
|
2022
Q1 | $8K | Sell |
1,990
-1,250
| -39% | -$4.54K | ﹤0.01% | 3489 |
|
|
2021
Q4 | $12K | Buy |
3,240
+1,250
| +63% | +$4.37K | ﹤0.01% | 3374 |
|
|
2021
Q3 | $7K | Hold |
1,990
| – | – | ﹤0.01% | 3572 |
|
|
2021
Q2 | $9K | Hold |
1,990
| – | – | ﹤0.01% | 3465 |
|
|
2021
Q1 | $8K | Hold |
1,990
| – | – | ﹤0.01% | 3393 |
|
|
2020
Q4 | $8K | Hold |
1,990
| – | – | ﹤0.01% | 3286 |
|
|
2020
Q3 | $5K | Hold |
1,990
| – | – | ﹤0.01% | 3327 |
|
|
2020
Q2 | $5K | Sell |
1,990
-508
| -20% | -$1.42K | ﹤0.01% | 3349 |
|
|
2020
Q1 | $6K | Hold |
2,498
| – | – | ﹤0.01% | 3221 |
|
|
2019
Q4 | $11K | Hold |
2,498
| – | – | ﹤0.01% | 3087 |
|
|
2019
Q3 | $8K | Hold |
2,498
| – | – | ﹤0.01% | 3138 |
|
|
2019
Q2 | $9K | Sell |
2,498
-7,884
| -76% | -$22.8K | ﹤0.01% | 3143 |
|
|
2019
Q1 | $31K | Buy |
10,382
+382
| +4% | +$1.24K | ﹤0.01% | 2699 |
|
|
2018
Q4 | $27K | Hold |
10,000
| – | – | ﹤0.01% | 2706 |
|
|
2018
Q3 | $34K | Hold |
10,000
| – | – | ﹤0.01% | 2743 |
|
|
2018
Q2 | $26K | Hold |
10,000
| – | – | ﹤0.01% | 2848 |
|
|
2018
Q1 | $22K | Hold |
10,000
| – | – | ﹤0.01% | 2923 |
|
|
2017
Q4 | $20K | Buy |
+10,000
| New | +$21.8K | ﹤0.01% | 2935 |
|
|
2016
Q2 | – | Sell |
-20
| Closed | – | – | 3677 |
|
|
2016
Q1 | $0 | Buy |
+20
| New | +$19 | ﹤0.01% | 3700 |
|
|
2015
Q2 | – | Sell |
-1,000
| Closed | -$3K | – | 3670 |
|
|
2015
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 3406 |
|
|
2014
Q4 | $3K | Buy |
+1,000
| New | +$2.25K | ﹤0.01% | 3390 |
|
Other funds holding ATRS
US Bancorp's ATRS Position: Q2 2022 in Review
US Bancorp sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,990 shares — an estimated $8K sold.
US Bancorp first reported a position in ATRS in Q4 2014 and held it in 21 quarters. The position peaked at $34K in Q3 2018. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- US Bancorp reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- US Bancorp sold 1,990 Antares Pharma, Inc. shares in Q2 2022, an estimated $8K.
- US Bancorp first reported a position in Antares Pharma, Inc. in Q4 2014 and held it in 21 quarters.
- US Bancorp's Antares Pharma, Inc. position peaked at $34K in Q3 2018.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on US Bancorp's 13F filing for Q2 2022, filed 1 Aug 2022.